Platform finder
Every platform below was checked on the vendor’s own pages, not on an aggregator. Filter by what you actually need — the type of system, the sector you work in, the features you cannot do without — and the list narrows. Conditions combine with AND, so each one you add cuts the list rather than growing it.
9 platforms of 67 match
A developer-facing image and video transformation API and CDN, billed from one pooled credit balance covering storage, transformations and bandwidth together.
A team file library billed as a flat monthly fee with unlimited users, aimed at organisations where most people only need to download an approved file a few times a month.
+ Price is published in full — three tiers with monthly and annual figures, rare in this market − Storage ceilings are modest — 20/50/100 GB, so video libraries outgrow the tiers quickly
An image and video CDN with an API-first asset library, built for fast developer integration, billed on flat monthly tiers with per-GB overage once bandwidth or storage limits are exceeded.
A compliance-focused DAM with built-in audit trails and multi-stage approval workflows, aimed at regulated industries like pharma, finance, insurance and franchise/multi-brand marketing teams.
A self-hosted file-sync and collaboration platform some organisations stretch into asset-library duty; tagging, batch metadata editing and dynamic tag-based collections are still limited or missing.
A free, self-hosted GPLv3 DAM used by French public-sector, cultural and broadcast institutions with in-house technical staff, now being sunset by its vendor in favor of a paid successor, Phrasea.
Profile not written yet — the facts below are verified, the summary is not.
An open-source PHP/Symfony platform unifying PIM, DAM, CMS and MDM on one codebase, for teams with in-house developers or an integrator partner rather than a marketing team wanting to self-serve.
A flat-fee-per-account DAM and MAM with a free 500GB/5-user tier and unlimited paid users, for teams willing to pilot without much recent independent review evidence.